Contact this trialFirst, we need to learn more about you.
AN0025 + Chemoradiation for Lung Cancer
Recruiting1 awardPhase 1
Atlanta, Georgia
This trial is testing the safety and effectiveness of a new drug, AN0025, for treating cancer. The drug will be given to patients in two different ways: after chemoradiation therapy, and during chemoradiation therapy. The trial will measure how well the drug works by looking at how long patients live without the cancer progressing, the percentage of patients whose cancer shrinks, and other measures.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.